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ABSTRACT
Background: Levobupivacaine, the S(-) isomer of bupivacaine, is less cardio-
oxic than racemic bupivacaine. Previous studies have examined different concentra-
ions of levobupivacaine in similar ways.
Objectives: This prospective, randomized, double-blind study was designed
to determine the clinical efficacy and hemodynamic effects of different concentrations
and equivalent volumes of levobupivacaine in epidural anesthesia. To our knowledge,
this is the first study to evaluate the effects of concentration lower than 0.5%
levobupivacaine.
Methods: Forty adult patients with an American Society of Anesthesiology
ASA) I–III physical status undergoing transurethral endoscopic surgery were ran-
omly divided into 2 groups to receive either 10 mL of isobaric levobupivacaine
0.5%  5 mL 0.9% saline [group 1; n  20]) or 10 mL of isobaric levobupivacaine
0.75%  5 mL saline 0.9% saline [group 2; n  20]) for epidural anesthesia. An
bserver blinded to group division evaluated the time of onset, maximum level, and
ime to 2-segment regression of sensory block.
Results: There were no differences between the 2 groups in terms of hemo-
dynamic parameters and time of onset of the sensory block. There were significant
differences, however, between the 2 groups in the maximum level of the sensory block
(group 1, T9; group 2, T8; P  0.010) and the time to 2-segment regression of
sensory block (group 1, 46.35 minutes; group 2, 62.94 minutes; P  0.013).
Conclusion: This study indicated that 10 mL of 0.5% levobupivacaine plus
mL of 0.9% saline is a suitable solution for use in epidural anesthesia because it
roduces a block clinically comparable to that of 10 mL of 0.75% levobupivacaine
lus 5 mL of 0.9% saline for transurethral resection of prostate surgery. (Curr Ther Res
lin Exp. 2011;72:71-78) © 2011 Elsevier HS Journals, Inc. All rights reserved.
Key words: anesthetic techniques, epidural, levobupivacaine.
This article was presented as a poster at the 27th Annual European Society of Regional Anesthesia (ESRA) Congress
on September 24–27, 2008, Genoa, Italy.
Accepted for publication March 10, 2011. doi:10.1016/j.curtheres.2011.03.0022011 Elsevier HS Journals, Inc. All rights reserved. 0011-393X/$ - see front matter
71
bS
b
w
Current Therapeutic ResearchINTRODUCTION
The cardiovascular effects of epidural anesthesia are predominantly related to the level
of analgesia and the dose of the local anesthetic. Patients undergoing transurethral
resection of the prostate are usually elderly and often have concomitant diseases that
compromise cardiovascular stability. In recent years, the reduced cardiotoxicity and
central nervous system toxicity associated with the use of levobupivacaine, the pure
(S-) enantiomer of bupivacaine, rather than bupivacaine, have been demonstrated in
preclinical studies,1–3 and many researchers have determined its potential benefits for
clinical use. Several studies have concluded that the faster protein-binding rate of
levobupivacaine reflects a decreased degree of toxicity.4 Although levobupivacaine has
een compared with other local anesthetics as an agent for epidural anesthesia,5–7
little information is available on the comparative clinical profile of epidural anesthesia
with different concentrations of levobupivacaine evaluating the quality of anesthesia.
In previous studies, the lowest concentration of levobubivacaine was 0.5% for
epidural anesthesia. Using a lower concentration of local anesthetics may confer
distinct advantages, such as avoiding motor blockade, adverse hemodynamic effects,
and serious complications associated with inadvertent intravascular injection. To our
knowledge, this is the first study to evaluate the effect of a concentration lower than
0.5% levobupivacaine. This study aimed to compare the clinical efficacy and hemo-
dynamic effects of different concentrations and equivalent volumes of levobupivacaine
in epidural anesthesia.
PATIENTS AND METHODS
After obtaining Institutional Ethics Committee of Sisli Etfal Training and Research
Hospital approval and written informed patient consent, 40 patients with an Amer-
ican Society of Anesthesiologists (ASA) physical status I through III, aged 55 to 75
years, who were undergoing transurethral resection of the prostate were prospectively
enrolled in this study. The study design was randomized, prospective, and double-
blinded. The patients receiving epidural anesthesia were randomly allocated to group
1 (Levo 5) or to group 2 (Levo 7.5), each composed of 20 patients. Computer-
generated randomization was achieved using sealed, numbered envelopes (1–40),
with each envelope containing 1 of 2 codes (Levo 5 or Levo 7.5). All subjects and
health care personnel providing direct patient care were blinded to the epidural
medications administered. All medications were prepared by a physician not other-
wise participating in the study. A physician also not involved in further patient care
opened the envelope and prepared sterile syringes.
On arrival in the operating room, a 20-gauge intravenous cannula was inserted and
standard monitoring was applied, including noninvasive arterial blood pressure (BP),
heart rate (HR), and pulse oximetry (SpO2). None of the patients received premed-
ication, but patients continued their routine medications. Before the block was
performed, all patients received 10 mL/kg-1 of isotonic saline over 20 minutes.
ystolic BP (SBP), diastolic BP (DBP), mean BP (MBP), HR, and SpO2 were recorded
efore anesthesia as baseline values and thereafter every 10 minutes until the patient
as discharged from the recovery room.
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D.B. Surav et al.With the patients in the lateral decubitus position after skin infiltration with 2 mL
of 2% lidocaine, an 18-gauge Tuohy needle (B. Braun, Melsungen, Germany) was
introduced at the L3–4 lumbar interspace, using the loss of resistance to saline
technique by a median approach. After a negative aspiration test, 3 mL of study drug
was injected as a test dose. A 20-gauge epidural catheter was advanced 3 to 4 cm into
the epidural space, and the needle was removed. The patient was then turned to the
supine position, and the remaining 12 mL of study drug was injected slowly with
repeated aspirations. Patients in group 1 (Levo 5) received 10 mL of levobupivacaine
(0.5%  5 mL saline), and patients in group 2 received 10 mL of levobupivacaine
(0.75%  5 mL saline) via the epidural catheter. The time to 2-segment regression
as the primary efficacy measurement. Secondary measurements were maximum
ensory block level, time to T10 sensory block, degree of motor block when sensory
lock reached to T10, and hemodynamic variables.
The following data were collected for every patient using a standardized form: age,
SA physical status, and type and duration of surgery. Immediately after the
njection of the local anesthetic, the level of sensory blockade was assessed and
ecorded every 2 minutes until a complete loss of pinprick sensation at T10 occurred,
nd thereafter every 10 minutes until a 2-segment regression of sensory block with
he blunt end of a 27-gauge dental needle was achieved on each side of the axillary
ine by an independent observer. The maximum level of sensory block, the time of
nset to achieve a T10 sensory block, and the time to 2-segment regression of sensory
lock were recorded. An adequate block to initiate surgery was defined as a sensory
lock bilaterally to dermatome T10. If the level of sensory block failed to reach the
10 dermatome after 20 minutes, a bolus dose of 5 mL of study solution was given
pidurally. If the sensory block level was still inadequate, general anesthesia was given
o the patient. When the sensory block reached T10, the motor block was also
ssessed using a modified Bromage scale by asking the patient to flex the hip, knee,
nd ankle joints against gravity (0, no block; 1, inability to flex the hip; 2, inability
o flex the hip and knee; and 3, inability to flex the hip, knee, and ankle). No sedation
as provided during surgery. Hemodynamic variables were recorded as baseline
preinjection), at the end of the injection, and thereafter every 10 minutes until the
atient was discharged from the recovery room. All other adverse events were
ecorded throughout the study.
A decrease of 30% from baseline or an absolute value of 90 mm Hg in SBP
as defined as hypotension and was an indication for treatment with intravenous
uids or intravenous ephedrine (bolus 5 mg). A HR of 50 beats per minute
bpm) was defined as bradycardia and was an indication for treatment with
ntravenous atropine (0.5 mg). All other adverse events, including nausea, vom-
ting, and shivering, were recorded throughout the study. In the recovery room,
ll patients were monitored, and hemodynamic changes and the time to 2-
egment regression of sensory blockade was recorded by a trained nurse. Patient
cceptance and willingness to have the same anesthetic technique administered
gain was questioned the day after surgery using the following 2-point scale: (1)
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Current Therapeutic Researchsatisfied, I would accept the same procedure; or (2) dissatisfied, I would prefer a
different anesthesia procedure.
Based on a pilot study, it was determined that 20 patients in each group would
confer an 80% power to detect a 20% difference in the time to 2-segment
regression of sensory block between the 2 groups. All statistical comparisons were
performed on the intent-to-treat patient population, with significance set at P 
0.05. The statistical analysis was performed using SPSS (SPSS, Inc., Chicago,
Illinois). Continuous variables were evaluated with analysis of variance (ANOVA),
and a 2-way ANOVA for repeated measures was used to analyze changes over
time. The t test, the Mann-Whitney test, and the 2 test were used when
appropriate. The results are presented as mean (SD). A P  0.05 was considered
significant. Continuous variables are presented as the mean (SD) or as the median
(range).
RESULTS
Forty patients were enrolled in the study. None of the patients required general
anesthesia or epidural supplementation of local anesthesia owing to failure of epidural
anesthesia, and no patient was excluded at any stage of the study. There were no
differences in the surgical management of the groups.
There were no significant differences between the groups regarding age, ASA
physical status, or duration of surgery (Table I). Patients in the 2 groups were
omparable regarding hemodynamic data, including lowest SBP, lowest DBP, lowest
BP, and lowest HR (Table II). The onset time to reach T10 sensory block was not
ignificantly different between groups (13.90 [3.45] vs 13.00 [5.53] minutes, for
roups 1 and 2, respectively; P  0.55). In group 2, the maximum level of sensory
block and the time to 2-segment regression of sensory block were significantly higher
than they were in group 1 (Table III). No difference in the degree of motor block was
observed between the 2 groups when the sensory block reached T10, and at this time
all patients had a Bromage score 1. No patient had hypotension or a bradycardic
episode during the study period. Eighteen (90%) patients in group 1 and 19 (95%)
patients in group 2 were willing to undergo the same anesthetic procedure for a future
Table I. Patients’ characteristics. Data are expressed as mean (SD).*
Group 1 (Levo 5) Group 2 (Levo 7.5) P
Age, y 67.7 (8.6) 65.3 (8.5) 0.4
Duration of surgery, min 69.5 (23.6) 68.0 (33.0) 0.87
ASA (I/II/III), n 3/15/2 3/11/5 0.32
n  number of patients, 2 test, t test.
*There were no significant differences between groups.surgery.
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D.B. Surav et al.DISCUSSION
This prospective, randomized, double-blind study found that 10 mL of levobupiva-
caine (0.5%  5 mL of 0.9% saline) induces a surgical block comparable in onset of
sensory block and degree of motor block to that of 10 mL of levobupivacaine (0.75%
 5 mL of 0.9% saline). However, the maximum level of sensory block was higher
and the time to 2-segment regression of the sensory block was longer in group 2 (Levo
7.5). The use of a low-concentration–equivalent volume of levobupivacaine provided
a quality of anesthesia similar to that of the high-concentration–equivalent volume of
levobupivacaine.
Levobupivacaine has pharmacokinetic properties similar to those of racemic bu-
pivacaine and is increasingly popular because of its lower cardiovascular and central
nervous system side effects.8 Results from comparative clinical studies of different
oncentrations of levobupivacaine for epidural anesthesia are limited5,7; studies of
oncentrations of levobupivacaine lower than 0.5% for epidural anesthesia have not
een published. Using a lower concentration of local anesthetics may confer distinct
dvantages, such as avoiding motor blockade and hemodynamic side effects, plus the
erious complications associated with inadvertent intravascular injection of local
nesthetic solution. In elderly patients, it is important to avoid hemodynamic side
ffects related to block height and doses of local anesthetics. Therefore, the block
Table II. Hemodynamic characteristics. Data are expressed as mean (SD).*
Group 1 (Levo 5) Group 2 (Levo 7.5) P†
Lowest SBP, mm Hg 132.20 (17.07) 130.68 (21.66) 0.81
Lowest DBP, mm Hg 72.50 (10.62) 70.11 (11.64) 0.46
Lowest MBP, mm Hg 92.15 (11.30) 87.70 (13.84) 0.36
Lowest HR, beats/min 67.55 (13.17) 68.00 (12.31) 0.62
DPB  diastolic blood pressure; HR  heart rate; MBP  mean blood pressure; SBP  systolic blood
pressure.
*There were no significant differences between groups.
†ANOVA.
Table III. Sensorial block characteristics. Data are expressed as mean (SD).*
Group 1 (Levo 5) Group 2 (Levo 7.5) P
ime to reach T10 (min) 13.90 (3.45) 13.00 (5.53) 0.55
ime to 2-segment regression (min) 46.35 (7.58) 62.94 (23.92)† 0.010
Maximum sensory block level‡ T9 (T7–T10) T8 (T5–T10)† 0.013
*t test.
†P  0.05 compared with group 1 (Levo 5).
‡Median (range), Mann-Whitney test.
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Current Therapeutic Researchheight should not be above that required for surgery. It is likely that using either a
lower volume or a lower concentration will be more appropriate to establish the block
height.
Cox et al5 reported that the time of onset of sensory block ranged between 8 and
minutes with 15 mL of 0.5% and 0.75% of levobupivacaine, respectively. Kopacz
t al observed the time of onset to surgical block at T10 within 13 minutes after
njecting 0.75% (20 mL)8 or 0.5% (15 mL) of levobupivacaine with the addition of
epinephrine and 0.5% (10 mL) of levobupivacaine without epinephrine.7 Casati et al6
found that the time of onset of sensory block was 27 minutes (range, 15–40 minutes)
with 0.5% (15 mL) of levobupivacaine. In that study, however, the total volume was
divided into 3 titrated boluses over a relatively longer period and impeded a
comparison with the previous studies. Peduto et al9 reported that using an epidural
block produced with 0.5% (15 mL) of levobupivacaine, the time of onset of sensory
block at T10 was 29 minutes; however, they injected 3 mL of the study drug after
negative aspiration for blood. After 5 minutes, the remaining 12 mL was injected
slowly to exclude intravascular injection. In our study, the time of onset of the sensory
block at T10 was 13 minutes in both groups. We injected 15 mL of the study drug
after repeated negative aspirations for blood.
In previous studies, the maximum upper spread of the sensory block was T5–6
with 0.75% of 20 mL8 and 0.5% of 15 mL of levobupivacaine with or without
epinephrine,7 T7 with 0.5% of 15 mL of levobupivacaine,6 and T8 with 0.75% or
.5% of 15 mL of levobupivacaine5 for epidural anesthesia . We found that the
aximum sensory block levels were T9 and T8 with 10 mL of 0.5% levobupivacaine
lus 5 mL of 0.9% saline and 10 mL of 0.75 levobupivacaine plus 5 mL of 0.9%
aline, respectively; these results are comparable with results from the previous
tudies.
In the present study, the time to 2-segment regression of sensory block was
ignificantly longer with 0.75% (10 mL) of levobupivacaine plus 5 mL of 0.9% saline
ersus 0.50% (10 mL) of levobupivacaine plus 5 mL of 0.09% saline (62 minutes vs
6 minutes, respectively). Kopacz et al7 reported that the time to 2-segment regres-
ion was 112 minutes after injecting 0.5% levobupivacaine (15 mL) with or without
pinephrine. Casati et al6 found a similar time to 2-segment regression with 0.5%
levobupivacaine (15 mL). In our study, increasing the concentration of levobupiva-
caine (group 2 [Levo 7.5], 62 minutes vs group 1 [Levo 5], 46 minutes) resulted in
a prolonged time to 2-segment regression.
A study evaluating the different concentrations of levobupivacaine that provide
effective epidural anesthesia showed that increasing the concentration of levobupiva-
caine (15 mL of 0.75% vs 0.5%) prolongs the duration of sensory and motor block
without increasing the incidence of adverse side effects.5 The concentration of
levobupivacaine solution determines the quality of anesthesia.10 However, increasing
both the volume and the concentration to 20 mL of 0.75% levobupivacaine is
associated with a high incidence of hypotension (82%) and delayed block regression.8
Using the same concentration and different volumes of levobupivacaine (15 mL vs
20 mL of 0.75%) indicated that the duration of sensory and motor block was
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D.B. Surav et al.significantly longer and that the maximum sensory dermatome level was higher
with 20 mL of levobupivacaine.5,8 Our study showed that the epidural injection
f 10 mL of 0.5% levobupivacaine plus 5 mL of 0.9% saline induces a surgical
lock of similar onset and intensity as 10 mL of 0.75% levobupivacaine plus 5 mL
f saline.
No differences in cardiovascular changes induced by the epidural block were
bserved in the 2 groups. Hypotension or bradycardia requiring treatment was not
bserved in the groups. This may be attributable to the saline solution infused before
he epidural block, the absence of intraoperative sedation, the characteristics of the
opulation studied, and the maximum level of sensory block.
The degree of motor block was similar between group 1 and group 2 when sensory
lock reached T10. According to the study design, adequate block to initiate surgery
as defined as a bilateral sensorial block at dermatome T10, and the degree of motor
lock was evaluated at this time. All patients had a degree of motor block 1.
ecause the time of onset of the motor block was slower than the time of onset of the
ensory block with levobupivacaine, these results are similar to those reported by
ther investigators evaluating the different volumes and concentrations of levobupi-
acaine via epidural injection.5,8 Indeed, no problems were reported by the surgeons
uring the procedure.
There are some minor significant differences between the 2 groups in this study.
hese differences were not clinically significant, and groups were comparable. Study
imitations include, first, small sample size. The size of the study population in our
nvestigation was too small to detect differences in some end points. It was deter-
ined on the basis of estimates of the time to 2-segment regression by using data
rom the pilot study and SD (15 minutes). Second, the degree of motor block was
ssessed when the level of sensory block was T10, as in our study protocol. The degree
f motor block was found 1 in both groups. Levobupivacaine shows a significantly
lower onset of lower extremity motor block than onset of sensory block.5,8 We could
not measure the degree of motor block during surgery because the surgery was
initiated and the patient was in the lithotomy position. Third, had we assessed the
complete recovery of sensory function, we might have uncovered statistically different
data. Cox et al reported that duration of sensory block was significantly longer in the
0.75% S(-) bupivacaine group (P  0.001 on the right, P  0.016 on the left), with
mean duration of 460 minutes compared with 377 minutes for 0.5% S(-) bupiva-
aine.5 There was no significant difference in onset time and maximum sensory block
level between the 2 groups.
CONCLUSION
The results of this prospective, randomized, double-blind study indicated that 10 mL
of 0.5% levobupivacaine plus 5 mL of 0.9% saline is a suitable solution for use in
epidural anesthesia because it produces a block clinically comparable with that
achieved with 10 mL of 0.75% levobupivacaine plus 5 mL of 0.9% saline for
transurethral resection in prostate surgery.
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